Wang C, Kang S G, Lee J, Sun Z, Kim C H
Laboratory of Immunology and Hematopoiesis, Department of Comparative Pathobiology, Purdue Cancer Center, Bindley Bioscience Center, Purdue University, West Lafayette, Indiana, USA.
Mucosal Immunol. 2009 Mar;2(2):173-83. doi: 10.1038/mi.2008.84. Epub 2009 Jan 7.
Migration and trafficking receptors of Th17 cells to mucosal tissues have been unclear. We report that Th17 cells preferentially migrate to the intestine and associated lymphoid tissues, and CCR6 is the homing receptor important for Th17 cell migration to certain tissue microenvironments of the intestine such as Peyer's patches and other sites where its ligand CCL20 is expressed. We found the cytokine transforming growth factor-beta1 is required for CCR6 expression whereas IL-2 suppresses it. CCR6-deficient Th17 cells aberrantly migrate to different compartments of the intestine. Surprisingly, administration of CCR6-deficient Th17 cells into severe combined immunodeficiency (SCID) mice led to excessive intestinal inflammation with increased Th1 but decreased Th17 cells and FoxP3(+) T cells. In addition, CCR6 deficiency led to aberrantly widespread effector T cells in the inflamed intestine of the SCID mice. We conclude that CCR6 regulates Th17 cell migration to the gut and effector T-cell balance/distribution in inflamed intestine.
Th17细胞向黏膜组织迁移和转运的受体尚不清楚。我们报告称,Th17细胞优先迁移至肠道及相关淋巴组织,且CCR6是Th17细胞迁移至肠道特定组织微环境(如派尔集合淋巴结以及其他表达其配体CCL20的部位)的归巢受体。我们发现细胞因子转化生长因子-β1是CCR6表达所必需的,而IL-2会抑制其表达。CCR6缺陷的Th17细胞会异常迁移至肠道的不同区域。令人惊讶的是,将CCR6缺陷的Th17细胞注射到严重联合免疫缺陷(SCID)小鼠体内会导致肠道炎症加剧,Th1细胞增多而Th17细胞和FoxP3(+) T细胞减少。此外,CCR6缺陷导致SCID小鼠炎症肠道中效应T细胞异常广泛分布。我们得出结论,CCR6调节Th17细胞向肠道的迁移以及炎症肠道中效应T细胞的平衡/分布。